A science powerhouse bets on genetic therapy to beat brain disorders
The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it breaks.
Read full article →Medicare Monitor
Tracking Medicare news, policy, and coverage changes.
Ebola vaccine candidates being fast-tracked to target rare strain
Three vaccine candidates are being fast-tracked to target the Ebola species spreading in Central Africa. Big organizations and companies are behind the effort, but logistics are complicated.
Read full article →5 takeaways on Trump's divisive Medicaid work requirements
A new rule explaining how states need to implement Medicaid work requirements may make it much harder for low-income sick people to maintain health coverage next year. The long-anticipated rule issued Monday is meant to guide 42 states and the District of Columbia on carrying out the work rules laid out in the One Big Beautiful Bill Act. GOP lawmakers and...
Read full article →Ilant Health Raises $15M to Advance Obesity Care
Ilant Health’s Series A round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX and AlphaLab. The post Ilant Health Raises $15M to Advance Obesity Care appeared first on MedCity News .
Read full article →Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
Read full article →Heat, bugs, germs: U.S. public health prepares for the World Cup
For months ahead of the World Cup, states and cities have been preparing to protect travelers and local communities from potential threats including foodborne illness and infectious diseases.
Read full article →Novel Biologic Performs Well in IgG4-Related Disease
(MedPage Today) -- LONDON -- An investigational monoclonal antibody drug for immunoglobulin (Ig)G4-related disease called obexelimab substantially outperformed placebo in the phase III INDIGO trial, researchers reported, positioning it to take...
Read full article →GLP-1 Drugs Cut Need for Knee Replacement
(MedPage Today) -- People with knee osteoarthritis (OA) who used GLP-1 receptor agonists were less likely to undergo knee replacement surgery, an analysis of a large records database indicated. Compared with otherwise similar OA patients not taking...
Read full article →Health Groups Unhappy With Medicaid Work Requirement Interim Rule
(MedPage Today) -- CMS issued an interim final rule Monday outlining implementation rules for new Medicaid work requirements, and health organizations seemed none too happy with it. "Most adults covered by Medicaid are already working, caregiving...
Read full article →Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer
(MedPage Today) -- CHICAGO -- Combining standard transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE regimen improved progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), the phase...
Read full article →Protein Won't Solve Our Nutrition Problem
(MedPage Today) -- Buffalo Wild Wings now offers an unusual new drink: "Espresso Proteini." Marketed for National Espresso Martini Day, the $12 drink includes 10 grams of Muscle Milk protein powder with a signature Buffalo dry rub rim. While the...
Read full article →Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries
(MedPage Today) -- CHICAGO -- Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients in low-resource countries with recurrent or metastatic head and neck squamous...
Read full article →